Anti-Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 32799709)

Published in J Am Heart Assoc on August 15, 2020

Authors

Oluremi N Ajala1,2, Olga V Demler1,2, Yanyan Liu1, Zareen Farukhi1,2, Steven J Adelman3, Heidi L Collins3, Paul M Ridker1,2,4, Daniel J Rader5, Robert J Glynn1,2, Samia Mora1,2,4

Author Affiliations

1: Center for Lipid Metabolomics and Division of Preventive Medicine Brigham and Women's Hospital Boston MA.
2: Harvard Medical School Boston MA.
3: VascularStrategies Plymouth PA.
4: Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA.
5: Department of Genetics University of Pennsylvania Philadelphia PA.

Associated clinical trials:

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events | NCT00239681